Equity (Details) - Schedule of compensation expense related to our stock-based awards - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Schedule Of Compensation Expense Related To Our Stock Based Awards Abstract | ||||
| Research and Development | $ 883 | $ 1,716 | $ 2,051 | $ 2,948 |
| General and Administrative | 1,012 | 1,184 | 2,193 | 2,300 |
| Total | $ 1,895 | $ 2,900 | $ 4,244 | $ 5,248 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|